Global RNAi for Therapeutic Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

REPORT SUMMARY
TABLE OF CONTENTS

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

RNAi for Therapeutic market report explains the definition, types, applications, major countries, and major players of the RNAi for Therapeutic market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

The report contains qualitative and quantitative analysis of the entire industry.

The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

By Player:
- Sirnaomics
- Silenseed
- Arrowhead, Dicerna Pharmaceuticals
- Quark Pharmaceuticals
- Arbutus Biopharma (Tekmira)
- Silence Therapeutics
- Benitec Biopharma
- Gradalis
- RXi Pharmaceuticals
- miRagen Therapeutics
- Alnylam Pharmaceuticals
- Sylentis
- Mirna Therapeutics
By Type:
- siRNA
- miRNA
- shRNA
By End-User:
- Cancer
- Cardiovascular
- HBV
- Other
By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- UK
- Spain
- France
- Italy
- Denmark
- Finland
- Norway
- Sweden
- Poland
- Russia
- Turkey
Asia-Pacific
- China
- Japan
- India
- South Korea
- Pakistan
- Bangladesh
- Indonesia
- Thailand
- Singapore
- Malaysia
- Philippines
- Vietnam
- Others
South America
- Brazil
- Colombia
- Chile
- Argentina
- Venezuela
- Peru
- Puerto Rico
- Ecuador
- Others
GCC
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates
Africa
- Nigeria
- South Africa
- Egypt
- Algeriat
- Others
Oceania
- Australia
- New Zealand
TABLE OF CONTENT
1. Global RNAi for Therapeutic Executive Summary
- 1.1 Introduction
- 1.2 Market Panorama, 2022
2 Coronavirus Impact
- 2.1 RNAi for Therapeutic Outlook to 2028- Original Forecasts
- 2.2 RNAi for Therapeutic Outlook to 2028- COVID-19 Affected Forecasts
- 2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
- 3.1 Potential Market Drivers and Opportunities
- 3.2 New Challenges and Strategies
- 3.3 Short Term and Long Term RNAi for Therapeutic Market Trends
4 Key Inferences
5 Market Overview
- 5.1 Current Market Scenario
- 5.2 Porter's Five Forces Analysis
6 Global RNAi for Therapeutic Market- Recent Developments
- 6.1 RNAi for Therapeutic Market News and Developments
- 6.2 RNAi for Therapeutic Market Deals Landscape
7 RNAi for Therapeutic Raw Materials and Cost Structure Analysis
- 7.1 RNAi for Therapeutic Key Raw Materials
- 7.2 RNAi for Therapeutic Price Trend of Key Raw Materials
- 7.3 RNAi for Therapeutic Key Suppliers of Raw Materials
- 7.4 RNAi for Therapeutic Market Concentration Rate of Raw Materials
- 7.5 RNAi for Therapeutic Cost Structure Analysis
8 Global RNAi for Therapeutic Import and Export Analysis (Top 10 Countries)
- 8.1 Global RNAi for Therapeutic Import by Region (Top 10 Countries) (2017-2028)
- 8.2 Global RNAi for Therapeutic Export by Region (Top 10 Countries) (2017-2028)
9 Global RNAi for Therapeutic Market Outlook by Types and Applications to 2022
- 9.1 Global RNAi for Therapeutic Consumption and Growth Rate by Type (2017-2022)
- 9.2 Global RNAi for Therapeutic Consumption and Growth Rate by Application (2017-2022)
10 Region and Country-wise RNAi for Therapeutic Market Analysis and Outlook till 2022
- 10.1 Global RNAi for Therapeutic Consumption (2017-2022)
- 10.2 North America Consumption Analysis
- 10.3 Europe Consumption Analysis
- 10.4 APAC Consumption Analysis
- 10.5 South America Consumption Analysis
- 10.6 GCC Consumption Analysis
- 10.7 Africa Consumption Analysis
- 10.8 Oceania Consumption Analysis
11 Global RNAi for Therapeutic Competitive Analysis
- 11.1 Sirnaomics
- 11.2 Silenseed
- 11.3 Arrowhead, Dicerna Pharmaceuticals
- 11.4 Quark Pharmaceuticals
- 11.5 Arbutus Biopharma (Tekmira)
- 11.6 Silence Therapeutics
- 11.7 Benitec Biopharma
- 11.8 Gradalis
- 11.9 RXi Pharmaceuticals
- 11.10 miRagen Therapeutics
- 11.11 Alnylam Pharmaceuticals
- 11.12 Sylentis
- 11.13 Mirna Therapeutics
12 Global RNAi for Therapeutic Market Outlook by Types and Applications to 2028
- 12.1 Global RNAi for Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)
- 12.2 Global RNAi for Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)
13 Country-wise RNAi for Therapeutic Market Analysis and Outlook to 2028
- 13.1 Global RNAi for Therapeutic Consumption Forecast (2022-2028)
- 13.2 North America Consumption Analysis
- 13.3 Europe Consumption Analysis
- 13.4 APAC Consumption Analysis
- 13.5 South America Consumption Analysis
- 13.6 GCC Consumption Analysis
- 13.7 Africa Consumption Analysis
- 13.8 Oceania Consumption Analysis
14 Conclusions
The List of Tables and Figures
- Table Definition of RNAi for Therapeutic
- Figure of RNAi for Therapeutic Picture
- Table Global RNAi for Therapeutic Import by Region (Top 10 Countries) (2017-2028)
- Table Global RNAi for Therapeutic Export by Region (Top 10 Countries) (2017-2028)
- Figure Global siRNA Consumption and Growth Rate (2017-2022)
- Figure Global miRNA Consumption and Growth Rate (2017-2022)
- Figure Global shRNA Consumption and Growth Rate (2017-2022)
- Figure Global Cancer Consumption and Growth Rate (2017-2022)
- Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)
- Figure Global HBV Consumption and Growth Rate (2017-2022)
- Figure Global Other Consumption and Growth Rate (2017-2022)
- Figure Global RNAi for Therapeutic Consumption by Country (2017-2022)
- Table North America RNAi for Therapeutic Consumption by Country (2017-2022)
- Figure United States RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Canada RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Mexico RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Table Europe RNAi for Therapeutic Consumption by Country (2017-2022)
- Figure Germany RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure UK RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Spain RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Belgium RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure France RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Italy RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Denmark RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Finland RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Norway RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Sweden RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Poland RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Russia RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Turkey RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Table APAC RNAi for Therapeutic Consumption by Country (2017-2022)
- Figure China RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Japan RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure India RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure South Korea RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Pakistan RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Bangladesh RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Indonesia RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Thailand RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Singapore RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Malaysia RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Philippines RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Vietnam RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Table South America RNAi for Therapeutic Consumption by Country (2017-2022)
- Figure Brazil RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Colombia RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Chile RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Argentina RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Venezuela RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Peru RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Puerto Rico RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Ecuador RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Table GCC RNAi for Therapeutic Consumption by Country (2017-2022)
- Figure Bahrain RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Kuwait RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Oman RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Qatar RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Saudi Arabia RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure United Arab Emirates RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Table Africa RNAi for Therapeutic Consumption by Country (2017-2022)
- Figure Nigeria RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure South Africa RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Egypt RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure Algeria RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Table Oceania RNAi for Therapeutic Consumption by Country (2017-2022)
- Figure Australia RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Figure New Zealand RNAi for Therapeutic Consumption and Growth Rate (2017-2022)
- Table Sirnaomics Company Details
- Table Sirnaomics RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Sirnaomics RNAi for Therapeutic Main Business and Markets Served
- Table Sirnaomics RNAi for Therapeutic Product Portfolio
- Table Silenseed Company Details
- Table Silenseed RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Silenseed RNAi for Therapeutic Main Business and Markets Served
- Table Silenseed RNAi for Therapeutic Product Portfolio
- Table Arrowhead, Dicerna Pharmaceuticals Company Details
- Table Arrowhead, Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Arrowhead, Dicerna Pharmaceuticals RNAi for Therapeutic Main Business and Markets Served
- Table Arrowhead, Dicerna Pharmaceuticals RNAi for Therapeutic Product Portfolio
- Table Quark Pharmaceuticals Company Details
- Table Quark Pharmaceuticals RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Quark Pharmaceuticals RNAi for Therapeutic Main Business and Markets Served
- Table Quark Pharmaceuticals RNAi for Therapeutic Product Portfolio
- Table Arbutus Biopharma (Tekmira) Company Details
- Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Main Business and Markets Served
- Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Portfolio
- Table Silence Therapeutics Company Details
- Table Silence Therapeutics RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Silence Therapeutics RNAi for Therapeutic Main Business and Markets Served
- Table Silence Therapeutics RNAi for Therapeutic Product Portfolio
- Table Benitec Biopharma Company Details
- Table Benitec Biopharma RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Benitec Biopharma RNAi for Therapeutic Main Business and Markets Served
- Table Benitec Biopharma RNAi for Therapeutic Product Portfolio
- Table Gradalis Company Details
- Table Gradalis RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Gradalis RNAi for Therapeutic Main Business and Markets Served
- Table Gradalis RNAi for Therapeutic Product Portfolio
- Table RXi Pharmaceuticals Company Details
- Table RXi Pharmaceuticals RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table RXi Pharmaceuticals RNAi for Therapeutic Main Business and Markets Served
- Table RXi Pharmaceuticals RNAi for Therapeutic Product Portfolio
- Table miRagen Therapeutics Company Details
- Table miRagen Therapeutics RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table miRagen Therapeutics RNAi for Therapeutic Main Business and Markets Served
- Table miRagen Therapeutics RNAi for Therapeutic Product Portfolio
- Table Alnylam Pharmaceuticals Company Details
- Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Alnylam Pharmaceuticals RNAi for Therapeutic Main Business and Markets Served
- Table Alnylam Pharmaceuticals RNAi for Therapeutic Product Portfolio
- Table Sylentis Company Details
- Table Sylentis RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Sylentis RNAi for Therapeutic Main Business and Markets Served
- Table Sylentis RNAi for Therapeutic Product Portfolio
- Table Mirna Therapeutics Company Details
- Table Mirna Therapeutics RNAi for Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
- Table Mirna Therapeutics RNAi for Therapeutic Main Business and Markets Served
- Table Mirna Therapeutics RNAi for Therapeutic Product Portfolio
- Figure Global siRNA Consumption Forecast and Growth Rate (2022-2028)
- Figure Global miRNA Consumption Forecast and Growth Rate (2022-2028)
- Figure Global shRNA Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
- Figure Global HBV Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
- Figure Global RNAi for Therapeutic Consumption Forecast by Country (2022-2028)
- Table North America RNAi for Therapeutic Consumption Forecast by Country (2022-2028)
- Figure United States RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Canada RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Mexico RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Table Europe RNAi for Therapeutic Consumption Forecast by Country (2022-2028)
- Figure Germany RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure UK RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Spain RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Belgium RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure France RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Italy RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Denmark RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Finland RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Norway RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Sweden RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Poland RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Russia RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Turkey RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Table APAC RNAi for Therapeutic Consumption Forecast by Country (2022-2028)
- Figure China RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Japan RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure India RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure South Korea RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Pakistan RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Bangladesh RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Indonesia RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Thailand RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Singapore RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Malaysia RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Philippines RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Vietnam RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Table South America RNAi for Therapeutic Consumption Forecast by Country (2022-2028)
- Figure Brazil RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Colombia RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Chile RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Argentina RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Venezuela RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Peru RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Puerto Rico RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Ecuador RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Table GCC RNAi for Therapeutic Consumption Forecast by Country (2022-2028)
- Figure Bahrain RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Kuwait RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Oman RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Qatar RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Saudi Arabia RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure United Arab Emirates RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Table Africa RNAi for Therapeutic Consumption Forecast by Country (2022-2028)
- Figure Nigeria RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure South Africa RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Egypt RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure Algeria RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Table Oceania RNAi for Therapeutic Consumption Forecast by Country (2022-2028)
- Figure Australia RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)
- Figure New Zealand RNAi for Therapeutic Consumption Forecast and Growth Rate (2022-2028)

RNAi for Therapeutic Market Report

Global RNAi for Therapeutic Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

1. Global RNAi for Therapeutic Executive Summary

2 Coronavirus Impact

3 Strategic Analytics to Boost Productivity and Profitability

4 Key Inferences

5 Market Overview

6 Global RNAi for Therapeutic Market- Recent Developments

7 RNAi for Therapeutic Raw Materials and Cost Structure Analysis

8 Global RNAi for Therapeutic Import and Export Analysis (Top 10 Countries)

9 Global RNAi for Therapeutic Market Outlook by Types and Applications to 2022

10 Region and Country-wise RNAi for Therapeutic Market Analysis and Outlook till 2022

11 Global RNAi for Therapeutic Competitive Analysis

12 Global RNAi for Therapeutic Market Outlook by Types and Applications to 2028

13 Country-wise RNAi for Therapeutic Market Analysis and Outlook to 2028

14 Conclusions

The List of Tables and Figures

Report Version Choose

Our Customers

Beyond Consulting, Future is Feasible

Quick Link

CONTACT US